SELLAS Life Sciences Group, Inc. SLS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$26.86M+13.0% | -$30.88M+17.3% | -$37.34M+9.6% | -$41.3M-99.5% | ||
| $1.96M+25.1% | $1.56M-25.3% | $2.09M+21.3% | $1.73M+70.7% | ||
| -$28.39M+19.8% | -$35.4M-12.7% | -$31.41M-31.9% | -$23.81M+8.5% | ||
| $86.3M+84.6% | $46.76M+109% | $22.34M-7.2% | $24.08M+99.4% | ||
| $61.01M— | —— | -$14.6M-245% | -$4.23M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does SELLAS Life Sciences Group, Inc. generate?
- SELLAS Life Sciences Group, Inc. (SLS) generated -$28.2M in operating cash flow over the trailing twelve months.
- Where does SELLAS Life Sciences Group, Inc.'s cash flow data come from?
- Every line is extracted from SELLAS Life Sciences Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.